Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus

16 Jul 2024

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Immunotherapy and Immune Responses
Influenza Virus Research Studies
Respiratory viral infections research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39013430
DOI: 10.1038/s41591-024-03189-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virusPMID 39013430Read ↗

Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protectionSemantic proximity Read ↗

A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A VirusSemantic proximity Read ↗

A clade 2.3.4.4b H5N1 virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteinsSemantic proximity Read ↗

Influenza B: Prospects for the Development of Cross-Protective VaccinesSemantic proximity Read ↗

Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of MiceSemantic proximity Read ↗

Antibody germline characterization of cross-neutralizing human IgGs against 4 serotypes of dengue virusSemantic proximity Read ↗

Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferretsSemantic proximity Read ↗

Assessment of cross-reactive neutralizing antibodies induction against H5N1 clade 2.3.4.4b by prior seasonal influenza immunization in retail workersSemantic proximity Read ↗

Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boostSemantic proximity Read ↗

A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinSemantic proximity Read ↗

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza virusesSemantic proximity Read ↗

Extent of Antigenic Cross-Reactivity among Highly Pathogenic H5N1 Influenza VirusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.